Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Seminars in Thrombosis and Hemostasis|April 16, 2004
Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugsJeanine M Walenga, Walter P Jeske, M Margaret Prechel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2004
Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparinPraveen Kumar, Debra A Hoppensteadt, M Margaret Prechel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 20, 2013
Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopeniaJeanine M Walenga, Margaret Prechel, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 14, 2018
Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without DiabetesMargaret Prechel, Susan Hudec, Elizabeth Lowden, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass graftingBrian R Untch, Walter P Jeske, Jeffrey Schwartz, et al.
British Journal of Haematology|August 2, 2008
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopeniaJeanine M Walenga, Margaret Prechel, Walter P Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2012
Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopeniaReiko Asada, Keiko Wanaka, Jeanine Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 1, 2008
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testingJeanine M Walenga, Amanda F Drenth, Myttle Mayuga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 14, 2014
Sustained release of tissue factor following thrombosis of lower limb traumaJeanine M Walenga, Phoebe C Kaiser, M Margaret Prechel, et al.
Texas Heart Institute Journal|March 18, 2003
Heparin-induced thrombocytopenia with associated thrombosis in children after the Fontan operation: report of two casesRosalia Porcelli, Bonnie C Moskowitz, Frank Cetta, et al.
Pageof 3